Purchase Order SPE2DP24P0539
Award Date 5/20/24
Potential Completion Date 6/4/24
Potential Value $2K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sacramento, CA 95825, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $2,010.06, was issued by the Medical Supply Chain division of the Department of Defense to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the purchase of 8510598440 - Naloxone Hydrochloride, a critical medication used to reverse opioid overdoses. The contract is a firm fixed-price purchase order with a completion date of May 13, 2024. The Maclean Group LLC is an...
- The federal contract award, valued at $4,020.12, was issued by the Medical Supply Chain agency of the Department of Defense to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510598613 - Naloxone Hydrochloride, a medication used to reverse opioid overdose. This is a firm fixed-price purchase order contract with a completion date of May 13, 2024. The Maclean Group LLC is an ISO...
- This federal contract award, valued at $1,005.03, was issued by the Department of Defense's Medical Supply Chain agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The Maclean Group holds several other significant federal contracts, including a $2.63 million Federal Supply Schedule contract with the Department of...
- This is a firm fixed price purchase order contract awarded by the Medical Supply Chain, a component of the Department of Defense, to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract, valued at $2,010.06, is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has a performance period ending on May 10, 2024. The Maclean Group is an ISO 9001:2015 certified...
- This federal contract award, valued at $1,005.03, was issued by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the purchase of naloxone hydrochloride, a critical drug used to reverse opioid overdoses. The Maclean Group has an extensive history of providing a wide range of medical equipment, water treatment systems, and other products and...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,010.06 firm-fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride, a medication used to reverse opioid overdose. This contract has an ultimate completion date of May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that holds several...
- This federal contract award, valued at $5,025.15, was issued by the Medical Supply Chain division of the Defense Department to The Maclean Group LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose. This is a firm fixed price purchase order with a completion date of July 11, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical...
- This federal contract award, valued at $1,005.03, was issued by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been awarded numerous prime federal...
- The U.S. Department of Defense's Medical Supply Chain agency has awarded a firm fixed-price purchase order contract valued at $1,005.03 to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has an ultimate completion date of May 10, 2024. The Maclean Group is an ISO 9001:2015 certified medical and...
- This federal contract award, valued at $1,005.03, was issued by the Defense agency Medical Supply Chain to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510987189 - Naloxone Hydrochloride, a medication used to reverse opioid overdose. The Maclean Group LLC has secured this firm-fixed price purchase order with an ultimate completion date of November 13, 2024. The company has established...